CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Eli Lilly and Company v. Eagle Pharmaceuticals, Inc.

1:17-cv-01293

Overview

Case Number 1:17-cv-01293
Filing Date 2017-09-11
Status Terminated
Termination Date 2019-12-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Eagle Pharmaceuticals, Inc. Operating Company

Represented By

8 Attorneys Listed

Renee Mosley Delcollo

Greenberg Traurig LLP

Tel: +1 (302) 661-7367

1007 North Orange Street, Suite 1200

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Wanda D. French-Brown

Email: wfrenchbrown@mcguirewoods.com

Joseph K. Yarsky

Email: jyarsky@mcguirewoods.com

Jeanna M. Wacker

Email: jeanna.wacker@kirkland.com

Irene E. Hudson

Email: ihudson@mcguirewoods.com

Benjamin C. Hsing

Email: bhsing@mcguirewoods.com

Sara M. Metzler

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7869
Fax: +1 (302) 498-7869

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Eli Lilly and Company Operating Company

Represented By

10 Attorneys Listed

Michael Xun Liu

Email: mliu@wc.com

Galina I. Fomenkova

Email: gfomenkova@wc.com

Dov P. Grossman

Email: dgrossman@wc.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

David M. Krinsky

Email: dkrinsky@wc.com

Andrew P. Lemens

Email: ALemens@wc.com

Adam L. Perlman

Email: adam.perlman@lw.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Alec T. Swafford

Email: aswafford@wc.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 10 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (10 found):
PTAB: 10
USPTO PTAB Trial 2016-07-14
IPR2016-01429

Apotex Inc. et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-08
IPR2016-01393

Wockhardt Bio AG et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-01
IPR2016-01191

Apotex Inc. et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-01
IPR2016-01343

Teva Pharmaceuticals USA, Inc. et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-01
IPR2016-01190

Apotex Inc. et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-01
IPR2016-01341

Teva Pharmaceuticals USA, Inc. et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-07-01
IPR2016-01340

Teva Pharmaceuticals USA, Inc. et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-06-30
IPR2016-01335

Wockhardt Bio AG et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-06-30
IPR2016-01337

Wockhardt Bio AG et al. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2015-12-14
IPR2016-00318

Sandoz Inc. v. Eli Lilly and Company

Asserted Patent
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7772209
Antifolate combination therapies
Filed: 2007-07-11
Issued: 2010-08-10
Expired (Term Ended)
Expires: 2021-11-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

51

Dispositive

2

Granted

0

Denied

1

Pending / Review

46

Motions by Category

Motion to Dismiss 1 Claim Construction / Markman Filing 25 Procedural / Extension Motion 15 Motion for Summary Judgment (Rule 56) 1 Motion to Strike / Sanctions 9

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Denied
ORDER, after oral argument on defendant Eagle Pharmaceutical's request to file a motion for summary judgment, and for the reasons stated on the record, it is he...
Entry #123 • 2019-05-01 Document →
Motion to Dismiss Pending
***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynges jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and...
Entry #— • 2017-09-13
Procedural / Extension Motion Pending / Under Review
ORDER Approving 161 STIPULATION TO EXTEND TIME to Submit Pretrial Order to October 11, 2019 filed by Eli Lilly and Company. Signed by Judge Mitchell S. Goldberg...
Entry #162 • 2019-10-08 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Submit Pretrial Order to October 11, 2019 - filed by Eli Lilly and Company. (Fahnestock, Derek) (Entered: 10/07/2019)
Entry #161 • 2019-10-07 Document →
Motion to Strike / Sanctions Pending / Under Review
[SEALED] REPLY BRIEF re 131 MOTION to Strike filed by Eagle Pharmaceuticals, Inc.. (Farnan, Kelly) (Entered: 07/26/2019)
Entry #147 • 2019-07-26 Document →
Motion to Strike / Sanctions Pending / Under Review
REDACTED VERSION of 144 Answering Brief in Opposition, to Motion to Strike Portions of Eli Lilly and Company's Opening Expert Reports by Eli Lilly and Company. ...
Entry #145 • 2019-07-23 Document →

Docket Entries

(237 total)
Pleading / Complaint

COMPLAINT filed against Eagle Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2221411.) - filed by Eli Lilly and Company. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(fms) (Entered: 09/12/2017)

Entry #1 • 2017-09-11
1
Pleading / Complaint

COMPLAINT filed against Eagle Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2221411.) - filed by Eli Lilly and Company. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(fms) (Entered: 09/12/2017)

Entry #1 • 2017-09-11
2
Pleading / Complaint

COMPLAINT filed against Eagle Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2221411.) - filed by Eli Lilly and Company. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(fms) (Entered: 09/12/2017)

Entry #1 • 2017-09-11
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) (Entered: 09/12/2017)

Entry #2 • 2017-09-11
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,772,209 B2. (fms) (Entered: 09/12/2017)

Entry #3 • 2017-09-11
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc